Enveric Biosciences ENVB

$ 1.57 9.79%

Quarterly report 2026-Q1
added 05-15-2026

Country	USA
IPO year	-
Industry	-
Stock Exchange	NASDAQ CAPITAL

Shares	335 K
Market Cap^[1]	$ 526 K
EBITDA (LTM)	$ -8.02 M
P/E (LTM)	-0.16
P/S (LTM)	0.02
EPS (LTM)	-14.08

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.